Rickettsia conorii IgM Antibody Test
Detect early exposure to Mediterranean spotted fever.
The Rickettsia conorii IgM Antibody Test is a blood test used to detect early immune responses to Rickettsia conorii, the bacterium that causes Mediterranean spotted fever (also known as boutonneuse fever). This test is primarily for individuals who have developed symptoms suggestive of a tick-borne infection after travel to or residence in endemic areas (such as parts of southern Europe, Africa, and the Middle East), or for those who have had known tick exposure. It helps identify a recent or acute infection by measuring IgM antibodies, which typically appear early in the course of the illness.
Biomarkers
Rickettsia conorii IgM Antibody
- Rickettsia conorii IgM Antibody: Detects the presence of IgM class antibodies directed against Rickettsia conorii, indicating a recent or current infection.
Why it matters
Early detection of Rickettsia conorii infection allows for timely medical intervention and appropriate management of Mediterranean spotted fever, which can be serious if left untreated. This test provides valuable information to support clinical decision-making, especially for travellers or residents in endemic regions presenting with compatible symptoms.
Rickettsia conorii IgM Antibody
- Rickettsia conorii IgM Antibody
No special preparation required.
For blood tests, we recommend drinking plenty of water beforehand to ensure smooth sample collection. If you are taking any regular medication, continue to do so unless advised otherwise by your doctor.
Important Clinical Information:
This test is a screening tool to monitor and support your overall health. It does not replace your GP or consultant.
Always discuss your test results, especially any abnormal results, with your GP, who can interpret them in the context of your medical history and overall health.